NO20060908L - Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse - Google Patents

Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse

Info

Publication number
NO20060908L
NO20060908L NO20060908A NO20060908A NO20060908L NO 20060908 L NO20060908 L NO 20060908L NO 20060908 A NO20060908 A NO 20060908A NO 20060908 A NO20060908 A NO 20060908A NO 20060908 L NO20060908 L NO 20060908L
Authority
NO
Norway
Prior art keywords
tazole
substituted
preparation
dioxide derivatives
benzoisothiazole
Prior art date
Application number
NO20060908A
Other languages
English (en)
Norwegian (no)
Inventor
Karl-Heinz Baringhaus
Norbert Tennagels
Guenter Mueller
Stefan Petry
Original Assignee
Sanofi Aventis Deutschland
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Aventis Deutschland filed Critical Sanofi Aventis Deutschland
Publication of NO20060908L publication Critical patent/NO20060908L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20060908A 2003-07-28 2006-02-24 Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse NO20060908L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10334309A DE10334309A1 (de) 2003-07-28 2003-07-28 Substituierte Thiazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
PCT/EP2004/007847 WO2005012295A1 (fr) 2003-07-28 2004-07-15 Derives de dioxyde de thiazol-benzoisothiazol substitues, procedes pour leur production et leur utilisation

Publications (1)

Publication Number Publication Date
NO20060908L true NO20060908L (no) 2006-02-24

Family

ID=34111694

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20060908A NO20060908L (no) 2003-07-28 2006-02-24 Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse

Country Status (37)

Country Link
EP (1) EP1651644B1 (fr)
JP (1) JP2007500145A (fr)
KR (1) KR20060052886A (fr)
CN (1) CN100413862C (fr)
AR (1) AR045113A1 (fr)
AT (1) ATE346065T1 (fr)
AU (1) AU2004261370B2 (fr)
BR (1) BRPI0412997A (fr)
CA (1) CA2533673A1 (fr)
CR (1) CR8202A (fr)
CY (1) CY1105962T1 (fr)
DE (2) DE10334309A1 (fr)
DK (1) DK1651644T3 (fr)
EC (1) ECSP066326A (fr)
ES (1) ES2276319T3 (fr)
GT (1) GT200400146A (fr)
IL (1) IL173289A0 (fr)
JO (1) JO2449B1 (fr)
MA (1) MA27932A1 (fr)
MY (1) MY141197A (fr)
NO (1) NO20060908L (fr)
NZ (1) NZ544975A (fr)
OA (1) OA13198A (fr)
PA (1) PA8607201A1 (fr)
PE (1) PE20050326A1 (fr)
PL (1) PL1651644T3 (fr)
PT (1) PT1651644E (fr)
RS (1) RS20060015A (fr)
RU (1) RU2350613C2 (fr)
SA (1) SA04250332B1 (fr)
SI (1) SI1651644T1 (fr)
TN (1) TNSN06030A1 (fr)
TW (1) TW200524923A (fr)
UA (1) UA83057C2 (fr)
UY (1) UY28443A1 (fr)
WO (1) WO2005012295A1 (fr)
ZA (1) ZA200510378B (fr)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004026532A1 (de) * 2004-05-29 2006-01-05 Sanofi-Aventis Deutschland Gmbh Substituierte Oxazol-Benzoisothiazoldioxidderivate, Verfahren zu deren Herstellung und deren Verwendung
EP2418202B1 (fr) 2006-03-31 2014-01-29 Novartis AG Dérivés (4-[4-[5-(substituted amino)-pyridin-2-yl]phenyl]-cyclohexyl)-acetic acid en tant qu'inhibiteurs de DGAT
EP2061767B1 (fr) 2006-08-08 2014-12-17 Sanofi Imidazolidin-2,4-diones arylaminoaryl-alkyl-substituées, procédé de fabrication, médicaments les contenant et leur utilisation
EP2025674A1 (fr) 2007-08-15 2009-02-18 sanofi-aventis Tetrahydronaphthaline substituée, son procédé de fabrication et son utilisation en tant que médicament
UY31968A (es) 2008-07-09 2010-01-29 Sanofi Aventis Nuevos derivados heterocíclicos, sus procesos para su preparación, y sus usos terapéuticos
WO2010068601A1 (fr) 2008-12-08 2010-06-17 Sanofi-Aventis Hydrate de fluoroglycoside hétéroaromatique cristallin, ses procédés de fabrication, ses procédés d'utilisation et compositions pharmaceutiques le contenant
KR20120060207A (ko) 2009-08-26 2012-06-11 사노피 신규한 결정성 헤테로방향족 플루오로글리코시드 수화물, 이들 화합물을 포함하는 약제 및 이들의 용도
WO2011107494A1 (fr) 2010-03-03 2011-09-09 Sanofi Nouveaux dérivés aromatiques de glycoside, médicaments contenants ces composés, et leur utilisation
EP2582709B1 (fr) 2010-06-18 2018-01-24 Sanofi Dérivés d'azolopyridin-3-one en tant qu'inhibiteurs de lipases et de phospholipases
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
US8895547B2 (en) 2011-03-08 2014-11-25 Sanofi Substituted phenyl-oxathiazine derivatives, method for producing them, drugs containing said compounds and the use thereof
EP2766349B1 (fr) 2011-03-08 2016-06-01 Sanofi Dérivés d'oxathiazine substitués par des carbocycles ou des hétérocycles, leur procédé de préparation, médicaments contenant ces composés et leur utilisation
WO2012120058A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés d'oxathiazine substitués par des groupes benzyle ou hétérométhylène, leur procédé de production, leur utilisation comme médicament ainsi que produits pharmaceutiques les contenant et leur utilisation
US8828994B2 (en) 2011-03-08 2014-09-09 Sanofi Di- and tri-substituted oxathiazine derivatives, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
WO2012120056A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés oxathiazine tétra-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
EP2683699B1 (fr) 2011-03-08 2015-06-24 Sanofi Dérivés oxathiazine di- et tri-substitués, procédé pour leur préparation, utilisation en tant que médicament, agent pharmaceutique contenant ces dérivés et utilisation
EP2683702B1 (fr) 2011-03-08 2014-12-24 Sanofi Nouveaux dérivés de phényle-oxathiazine substitués, leur procédé de fabrication, médicament contenant ces liaisons et son utilisation
EP2683704B1 (fr) 2011-03-08 2014-12-17 Sanofi Dérivés oxathiazine ramifiés, procédé pour leur préparation, utilisation en tant que médicament, agents pharmaceutiques contenant ces dérivés et leur utilisation
WO2012120051A1 (fr) 2011-03-08 2012-09-13 Sanofi Dérivés benzyl-oxathiazine substitués avec adamantane ou noradamantane, médicaments contenant ces composés et leur utilisation
WO2013037390A1 (fr) 2011-09-12 2013-03-21 Sanofi Dérivés amides d'acide 6-(4-hydroxyphényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
EP2567959B1 (fr) 2011-09-12 2014-04-16 Sanofi Dérivés d'amide d'acide 6-(4-hydroxy-phényl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylique en tant qu'inhibiteurs de kinase
WO2013045413A1 (fr) 2011-09-27 2013-04-04 Sanofi Dérivés d'amide d'acide 6-(4-hydroxyphényl)-3-alkyl-1h-pyrazolo[3,4-b] pyridine-4-carboxylique utilisés comme inhibiteurs de kinase
AU2019318209B2 (en) 2018-08-10 2025-09-25 Diapin Therapeutics, Llc Tri-peptides and treatment of metabolic, cardiovascular and inflammatory disorders
WO2025017207A1 (fr) * 2023-07-20 2025-01-23 Cemm - Forschungszentrum Für Molekulare Medizin Gmbh Inhibiteurs de smndc1 et leur utilisation thérapeutique

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3539584A (en) * 1967-11-14 1970-11-10 Colgate Palmolive Co 5-substituted-2,1-benzisothiazolines
JPH04128276A (ja) * 1990-09-19 1992-04-28 Pfizer Pharmaceut Co Ltd アミノベンゾサルタム誘導体およびその用途
KR100457502B1 (ko) * 1995-06-02 2005-09-05 사노피-신델라보 옥사졸리디논유도체,그것의제법및치료학적사용
CO5190696A1 (es) * 1999-06-16 2002-08-29 Smithkline Beecham Corp Antagonistas de los receptores il-8
DE10038709A1 (de) * 2000-08-09 2002-02-28 Aventis Pharma Gmbh Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen

Also Published As

Publication number Publication date
RU2006106231A (ru) 2006-06-27
DE10334309A1 (de) 2005-03-03
DK1651644T3 (da) 2007-03-26
PA8607201A1 (es) 2005-03-03
UY28443A1 (es) 2005-02-28
NZ544975A (en) 2010-02-26
CN1829715A (zh) 2006-09-06
AR045113A1 (es) 2005-10-19
IL173289A0 (en) 2006-06-11
ES2276319T3 (es) 2007-06-16
SI1651644T1 (sl) 2007-02-28
TW200524923A (en) 2005-08-01
PL1651644T3 (pl) 2007-03-30
JP2007500145A (ja) 2007-01-11
RU2350613C2 (ru) 2009-03-27
GT200400146A (es) 2005-08-12
MA27932A1 (fr) 2006-06-01
EP1651644B1 (fr) 2006-11-22
ZA200510378B (en) 2006-11-29
CR8202A (es) 2008-10-15
JO2449B1 (en) 2008-10-09
SA04250332B1 (ar) 2008-02-25
CY1105962T1 (el) 2011-04-06
KR20060052886A (ko) 2006-05-19
UA83057C2 (ru) 2008-06-10
AU2004261370A1 (en) 2005-02-10
EP1651644A1 (fr) 2006-05-03
HK1091825A1 (en) 2007-01-26
AU2004261370B2 (en) 2009-07-16
MY141197A (en) 2010-03-31
CN100413862C (zh) 2008-08-27
ECSP066326A (es) 2006-07-28
PE20050326A1 (es) 2005-06-16
BRPI0412997A (pt) 2006-10-03
DE502004002117D1 (de) 2007-01-04
PT1651644E (pt) 2007-01-31
RS20060015A (sr) 2007-12-31
OA13198A (en) 2006-12-13
ATE346065T1 (de) 2006-12-15
TNSN06030A1 (en) 2007-10-03
WO2005012295A1 (fr) 2005-02-10
CA2533673A1 (fr) 2005-02-10

Similar Documents

Publication Publication Date Title
NO20060908L (no) Substituerte tazol-benzoisotiazoldioksidderivater, deres fremstilling og anvendelse
NO20065926L (no) Substituerte oksazolbenzoisotiazoldioksidderivater samt fremgangsmate for fremstilling og anvendelse derav
NO20050648L (no) Heterocyklisk substituerte benzoylureaer, fremgangsmate for fremstilling derav og deres anvendelse som medikamenter
NO20044882L (no) Acyl-4-karboksylfenylurinstoffderivater, deres fremstilling og anvendelse
NO20064201L (no) Glukopyranosylsubstituerte benzolderivater, medikamenter inneholdende slike forbindelser, deres anvendelse og fremstilling
NO20073831L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
MX2009003958A (es) Nuevos derivados de 1,4-benzotiepina-1,1-dioxido sustituidos con radicales bencilo, metodo para su preparacion, productos farmaceuticos que comprenden estos compuestos y su uso.
NO20050828L (no) lndol-3-svovelderivater
NO20055887L (no) Pyrido'2, 1-A-isokinoliderivater som DPP-IV-inhibitorer
NO20082445L (no) Neuropeptid-2 reseptor-agonister
NO20051165L (no) Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet
NO20081844L (no) Terapeutiske forbindelser
NO20070224L (no) 2-karbamid-4-fenyltiazolderivater, fremstilling og terapeutisk anvendelse derav
WO2004072031A3 (fr) Composes d'amides substitues tri(cyclo)
NO20074703L (no) Antibakterielle piperidinderivater
NO20085064L (no) 4,5-difenyl-pyrimidinyl-oksy eller -merkaptosubstituerte karboksylsyrer, fremgangsmate for deres fremstilling og anvendelse derav som medikamenter
NO20055680L (no) Heksahydropyridoisokinoliner som DPP-IV-inhibitorer
EP2397462A3 (fr) Composés, compositions et méthodes de traitement de l'insuffisance cardiaque
NO20074872L (no) Pyrazoler
NO20082496L (no) Pyrazinderivater
NO20073830L (no) Medikamenter for behandling eller forebygging av fibrotiske sykdommer
NO20050134L (no) Difenylazetidioner substituert med syregrupper, fremgangsmate for fremstilling av disse, medikamenter inneholdende disse forbindelser og deres anvendelse
NO20055766L (no) Positive modulatorer av nikotinacetylcholinreseptorer
NO20082727L (no) Salter av 9-oksoakridin-10-eddiksyre med 1-alkylamino-1-deoksypolyoler
NO20062491L (no) Benzoksazinderivter og deres anvendelse

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application